Skip to NavigationSkip to content

News

When used in addition to statins and LLTs, data presented at the digital event indicated that Nilemdo “significantly” reduced LDL-C in treated...
AstraZeneca has started a Phase 3 trial of its experimental coronavirus vaccines in the US, making it the third company to start late-stage trials of...
This mass testing system will be voluntary and utilise medical staff from mainland China, which has sparked fears the programme could be used for...
Overall, the drug did not help those with less severe cases of the virus and in some cases the trial environment led to COVID-19 pneumonia...
AstraZeneca took the opportunity at the digital ESC Congress 2020 to reveal promising new Phase 3 data on the addition of Farxiga to standard of...
A new breast cancer drug, called TTC-352, can halt the spread of the disease and is safe according to a Phase 1 clinical trial.
The US government has signed a deal to buy Abbott’s rapid coronavirus test after the FDA gave it Emergency Use Authorization earlier this week.
Researchers are set to investigate a combined dose of LSD and MDMA to treat patients undergoing psychotherapy.
Celltrion Group has announced that the Korean Ministry of Food and Drug Safety has approved the company’s Investigational New Drug application for a...
The top 10 news stories this week are focused on coronavirus vaccines and treatments, as China is set to move ahead with human testing of a potential...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches